X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5) 5
index medicus (5) 5
colorectal cancer (4) 4
female (4) 4
mutation (4) 4
oncology (4) 4
adult (3) 3
aged (3) 3
cancer (3) 3
gene expression (3) 3
male (3) 3
medical research (3) 3
middle aged (3) 3
survival (3) 3
aged, 80 and over (2) 2
biomarkers, tumor - genetics (2) 2
cetuximab (2) 2
chemotherapy (2) 2
colon cancer (2) 2
colonic neoplasms - genetics (2) 2
colonic neoplasms - pathology (2) 2
colonic neoplasms - surgery (2) 2
colorectal neoplasms - genetics (2) 2
computational biology (2) 2
consortia (2) 2
genetic aspects (2) 2
genomics (2) 2
hematology, oncology and palliative medicine (2) 2
hospitals (2) 2
medicine (2) 2
molecular genetics (2) 2
multivariate analysis (2) 2
neoplasm staging (2) 2
poor-prognosis (2) 2
proportional hazards models (2) 2
research (2) 2
research article (2) 2
studies (2) 2
1st-line treatment (1) 1
3' untranslated regions (1) 1
3122 cancers (1) 1
3123 gynaecology and paediatrics (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - surgery (1) 1
adenoma - genetics (1) 1
adjuvant treatment (1) 1
analysis (1) 1
animals (1) 1
antibodies (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - pharmacology (1) 1
antibodies, monoclonal, humanized (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic combined chemotherapy protocols (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apc (1) 1
apoptosis (1) 1
b raf kinase (1) 1
beta catenin - genetics (1) 1
beta catenin - metabolism (1) 1
beta-catenin (1) 1
bevacizumab (1) 1
binding sites (1) 1
binding-sites (1) 1
biology (1) 1
biology and life sciences (1) 1
breast (1) 1
breast cancer (1) 1
breast neoplasms (1) 1
breast neoplasms - diagnosis (1) 1
breast neoplasms - genetics (1) 1
cancer genetics (1) 1
care and treatment (1) 1
case-control studies (1) 1
casp8 gene (1) 1
cell biology (1) 1
cell differentiation (1) 1
cell lineage (1) 1
cell proliferation (1) 1
chemotherapy, adjuvant (1) 1
chi-square distribution (1) 1
child & adolescent psychiatry (1) 1
chromosome mapping (1) 1
class i phosphatidylinositol 3-kinases (1) 1
cluster analysis (1) 1
colon (1) 1
colonic neoplasms - classification (1) 1
colonic neoplasms - drug therapy (1) 1
colonic neoplasms - mortality (1) 1
colorectal neoplasms - drug therapy (1) 1
colorectal-cancer (1) 1
combination (1) 1
common variant (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 8, pp. 753 - 762
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 862 - 873
Summary Background Since the 1990s, fluorouracil-based adjuvant chemotherapy has significantly reduced the risk of tumour recurrence in patients with stage III... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST-LINE TREATMENT | THERAPY | ONCOLOGY | BEVACIZUMAB | ADJUVANT TREATMENT | NSABP C-07 | KRAS | COMBINATION | METASTATIC COLORECTAL-CANCER | CHEMOTHERAPY | ras Proteins - genetics | Colonic Neoplasms - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Colonic Neoplasms - drug therapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Diarrhea - chemically induced | Colonic Neoplasms - surgery | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Infusions, Intravenous - adverse effects | Adult | Female | Leucovorin - therapeutic use | Adenocarcinoma - genetics | Chemotherapy, Adjuvant | Cetuximab | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Exons - genetics | Proto-Oncogene Proteins - genetics | Adenocarcinoma - drug therapy | Mucositis - chemically induced | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colonic Neoplasms - pathology | Intention to Treat Analysis | Aged | Neoplasm Staging | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Adenocarcinoma - surgery | Prevention | Care and treatment | Chemotherapy | Colon cancer | Hospitals | Leucovorin | Product development | Cancer | Index Medicus | Life Sciences
Journal Article
PLoS Medicine, ISSN 1549-1277, 2013, Volume 10, Issue 5, p. e1001453
Journal Article
by Khan, Sofia and Greco, Dario and Michailidou, Kyriaki and Milne, Roger and Muranen, Taru and Heikkinen, Tuomas and Aaltonen, Kirsimari and Dennis, Joe and Bolla, Manjeet and Liu, Jianjun and Hall, Per and Irwanto, Astrid and Humphreys, Manjeet and Li, Jingmei and Czene, Kamila and Chang-Claude, Jenny and Hein, Rebecca and Rudolph, Anja and Seibold, Petra and Flesch-Janys, Dieter and Fletcher, Olivia and Peto, Julian and Santos Silva, Isabel and Johnson, Nichola and Gibson, Lorna and Aitken, A and Hopper, John and Tsimiklis, Helen and Bui, Minh and Makalic, Enes and Schmidt, Daniel and Southey, Melissa and Apicella, Carmel and Stone, Jennifer and Waisfisz, Quinten and Meijers-Heijboer, Hanne and Adank, Muriel and Luijt, Rob and Meindl, Alfons and Schmutzler, Rita and Müller-Myhsok, B and Lichtner, Peter and Turnbull, Clare and Rahman, Nazneen and Chanock, Stephen and Hunter, David and Cox, Angela and Cross, Simon and Reed, Malcolm and Schmidt, Marjanka and Broeks, Annegien and Veer, Laura and Hogervorst, Frans and Fasching, Peter and Schrauder, Ané and Ekici, Arif and Beckmann, Matthias and Bojesen, Stig and Nordestgaard, Børge and Nielsen, Sune and Flyger, Henrik and Benítez, Javier and Zamora, Pilar M and Perez, Jose Ignacio Arias and Haiman, Christopher and Henderson, Brian and Schumacher, Freick and March, Loic Le and Pharoah, Paul and Dunning, Alison and Shah, Mitul and Luben, Robert and Brown, Judith and Couch, Fergus and Wang, X and Vachon, Celine and Olson, Janet and Lambrechts, Diether and Moisse, Matthieu and Paridaens, Robert and Christiaens, Marie Rose and Guénel, Pascal and Truong, Thérèse and Laurent-Puig, Pierre and Mulot, Claire and Marme, Frederick and Burwinkel, Barbara and Schneeweiss, Aneas and Sohn, Christof and Sawyer, Elinor and Tomlinson, Ian and Kerin, Michael and Miller, Nicola and Anulis, Irene and Knight, Julia and Tchatchou, Srine and Mulligan, Anna-Marie and Dörk, Thilo and Bogdanova, Natalia and Antonenkova, Natalia and ... and KConFab Investigators and Australian Ovarian Canc Study Grp and GENICA Network and Australian Ovarian Cancer Study Group and kConFab Investigators and The GENICA Network
PLoS ONE, ISSN 1932-6203, 11/2014, Volume 9, Issue 11, p. e109973
Journal Article
PLoS Medicine, ISSN 1549-1277, 05/2013, Volume 10, Issue 5
  Background Colon cancer (CC) pathological staging fails to accurately predict recurrence, and to date, no gene expression signature has proven reliable for... 
Studies | Medical research | Colorectal cancer | Mutation | Gene expression
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.